Atlas Trials

Rituximab at Low dosE for neuromyelitiS optiCa spectrUm disordEr (RESCUE)

Clinical trial NCT04256252 · COMPLETED

Trial details

NCT number
NCT04256252
Sponsor
Tang-Du Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Neuromyelitis Optica Spectrum Disorder
Start date
2014-04-01
Primary completion
2020-04-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.